These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31640261)

  • 1. A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature.
    Zhao Z; Weickmann S; Jung M; Lein M; Kilic E; Stephan C; Erbersdobler A; Fendler A; Jung K
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31640261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy.
    Cheng B; He Q; Cheng Y; Yang H; Pei L; Deng Q; Long H; Zhu L; Jiang R
    Front Genet; 2019; 10():1402. PubMed ID: 32117427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
    Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
    Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
    Fredsøe J; Rasmussen AKI; Mouritzen P; Borre M; Ørntoft T; Sørensen KD
    Int J Cancer; 2019 Nov; 145(9):2558-2567. PubMed ID: 30903800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy.
    Bell EH; Kirste S; Fleming JL; Stegmaier P; Drendel V; Mo X; Ling S; Fabian D; Manring I; Jilg CA; Schultze-Seemann W; McNulty M; Zynger DL; Martin D; White J; Werner M; Grosu AL; Chakravarti A
    PLoS One; 2015; 10(3):e0118745. PubMed ID: 25760964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors.
    Rochow H; Jung M; Weickmann S; Ralla B; Stephan C; Elezkurtaj S; Kilic E; Zhao Z; Jung K; Fendler A; Franz A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?
    Zhao Z; Stephan C; Weickmann S; Jung M; Kristiansen G; Jung K
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
    Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC
    Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy.
    Strand SH; Bavafaye-Haghighi E; Kristensen H; Rasmussen AK; Hoyer S; Borre M; Mouritzen P; Besenbacher S; Orntoft TF; Sorensen KD
    Int J Cancer; 2019 Dec; 145(12):3445-3452. PubMed ID: 31125115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome.
    Strand SH; Schmidt L; Weiss S; Borre M; Kristensen H; Rasmussen AKI; Daugaard TF; Kristensen G; Stroomberg HV; Røder MA; Brasso K; Mouritzen P; Sørensen KD
    Sci Rep; 2020 Jul; 10(1):10704. PubMed ID: 32612164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.
    Shi R; Bao X; Weischenfeldt J; Schaefer C; Rogowski P; Schmidt-Hegemann NS; Unger K; Lauber K; Wang X; Buchner A; Stief C; Schlomm T; Belka C; Li M
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
    Zhang Q; Zhao K; Song L; Ji C; Cong R; Luan J; Zhou X; Xia J; Song N
    Front Genet; 2020; 11():586376. PubMed ID: 33329725
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
    Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. snRNAs from Radical Prostatectomy Specimens Have the Potential to Serve as Prognostic Factors for Clinical Recurrence after Biochemical Recurrence in Patients with High-Risk Prostate Cancer.
    Mikami H; Noguchi S; Akatsuka J; Hasegawa H; Obayashi K; Takeda H; Endo Y; Toyama Y; Takei H; Kimura G; Kondo Y; Takizawa T
    Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.